Xiangya Hospital of Central South University Clinical Trial Pipeline: 65 Active Trials, 19 Changes This Month

What changed in the last 30 days

7 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 5 with minor changes only.

Notable

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Primary endpoint(s) modified

Also in this update: Trial status changed: Unknown → Completed; Final enrollment: 750 participants (planned 600)

Xiangya Hospital of Central South UniversityNot specified NCT06503939 Registry history of NCT06503939 on ClinicalTrials.gov (opens the registry)

Updated Sep 22, 2026
Notable

Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring

Recruitment opened

Also in this update: Primary completion pushed from Aug 15, 2026 to Dec 31, 2026; Enrollment increased: 167 → 200 participants

Xiangya Hospital of Central South UniversityNot specified NCT07115459 Registry history of NCT07115459 on ClinicalTrials.gov (opens the registry)

Updated Sep 17, 2026

Show 5 trials with minor changes only

Minor

Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC

Trial completed

Also in this update: Final enrollment: 226 participants (planned 165); Primary completion moved earlier from Dec 31, 2024 to Aug 28, 2024

Xiangya Hospital of Central South UniversityNot specified NCT05932836 Registry history of NCT05932836 on ClinicalTrials.gov (opens the registry)

Updated Oct 5, 2026
Minor

ICU · Application of Different Sedation Protocols in ICU · Severe Pneumonia

Trial status changed: Unknown → Completed

Also in this update: Final enrollment: 260 participants (planned 600)

Xiangya Hospital of Central South UniversityNot specified NCT06514781 Registry history of NCT06514781 on ClinicalTrials.gov (opens the registry)

Updated Sep 21, 2026
Minor

Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics · Resectable NSCLC

Primary completion date changed from estimate of Sep 2027 to Dec 31, 2024

Also in this update: Interventions modified

Xiangya Hospital of Central South UniversityPhase 2 NCT04699721 Registry history of NCT04699721 on ClinicalTrials.gov (opens the registry)

Updated Oct 2, 2026
Minor
2 trials marked Unknown by the registry's verification sweep
1. Minor
  
  Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery
  
  Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  
  Xiangya Hospital of Central South UniversityPhase 4 NCT06663254 Registry history of NCT06663254 on ClinicalTrials.gov (opens the registry)
  
  Changed Oct 4, 2026
2. Minor
  
  TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma
  
  Registry marked status Unknown (sponsor has not verified the record since Nov 2022); last known: Recruiting
  
  Xiangya Hospital of Central South UniversityNot specified NCT05872880 Registry history of NCT05872880 on ClinicalTrials.gov (opens the registry)
  
  Changed Oct 4, 2026
Registry verification sweep

Changed Oct 4, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First posted	Trial	Phase	Status
2026-09-25	NCT07840950 Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques…		Not Yet Recruiting
2026-09-22	NCT07833410 Chinese Multicenter Cohort Study of Intracerebral Hemorrhage		Recruiting

Active trials by phase

Phase 1		2
Phase 1/2		1
Phase 2		1
Phase 3		2
Phase 4		5

Not charted: 54 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 65

NCT ID	Title	Condition	Status	Updated
Phase 4
NCT07412223	Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery	Pain, Postoperative	Recruiting	2026-08-17
NCT07373847	Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque…	Plaque Psoriasis	Not Yet Recruiting	2026-01-28
NCT07235995	Paracetamol and Mannitol Injection and Postoperative Delirium	Postoperative Delirium	Not Yet Recruiting	2025-11-19
NCT06530563	the Efficacy and Safety of Oliceridine Fumarate Injection for Acute Pain After Abdominal…	Acute Pain	Not Yet Recruiting	2025-08-19
NCT06825728	Metoprolol in Patients With HFrEF and COPD	Heart Failure With Reduced Ejection Fraction (HFrEF)	Not Yet Recruiting	2025-02-13
Phase 3
NCT07369999	Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild…	Mild Disabling Acute Ischemic Stroke	Recruiting	2026-08-03
NCT06704685	A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing…	ST-segment Elevation Myocardial Infarction (STEMI)	Not Yet Recruiting	2024-11-26
Phase 2
NCT04699721	Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in…	Non-small Cell Lung Cancer Stage II	Active, Not Recruiting	2026-10-02
Phase 1/2
NCT06866977	A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in…	Pancreatic Cancer	Not Yet Recruiting	2025-03-10
Phase 1
NCT07783815	A Study to Evaluate the Efficacy and Safety of Intravesical Instillation of Disitamab…	Bladder Cancer	Not Yet Recruiting	2026-08-25
NCT06882876	JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study	Hepatocellular Carcinoma (HCC)	Enrolling by Invitation	2025-09-19
Not applicable
NCT07369960	Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language…	Developmental Delay Disorder	Recruiting	2026-06-02
NCT07296497	Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety	Rosacea	Recruiting	2026-01-30
NCT06992843	Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest	Cardiac Arrest	Recruiting	2025-11-18
NCT06054633	L-arginine for Knee Osteoarthritis Patients	Osteoarthritis, Knee	Recruiting	2025-06-02
NCT05751733	Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST	Gastrointestinal Stromal Tumors	Recruiting	2023-03-02
NCT07840950	Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques…	Carotid Artery Plaques	Not Yet Recruiting	2026-09-25
NCT07754916	Comparison of Liposomal Bupivacaine Paravertebral Nerve Block Versus Intercostal Nerve…	Thoracic Surgery	Not Yet Recruiting	2026-08-12
NCT07750548	sirA-CPB Strategy Reduces New Ischemic/Embolic Lesions After Acute Type A Aortic…	Dissection, Aortic	Not Yet Recruiting	2026-08-06
NCT07667972	Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea	Melasma	Active, Not Recruiting	2026-06-30
NCT07649434	Effect of Biologic vs Synthetic Mesh on Chronic Pain After Laparoscopic Repair of…	Hernia Inguinal	Not Yet Recruiting	2026-06-16
NCT07594951	Effect of Different Bed Head Angles on Intraoperative Hypoxemia in Patients Undergoing…	Hypoxemia	Not Yet Recruiting	2026-05-19
NCT07276620	Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and…	Atopic Dermatitis (AD)	Not Yet Recruiting	2025-12-11
NCT07080879	The Advantages and Disadvantages of Linear Anastomat and Tubular Anastomat in Radical…	Gastric Cancer	Active, Not Recruiting	2025-07-23
Not specified
NCT07833410	Chinese Multicenter Cohort Study of Intracerebral Hemorrhage	Intracerebral Hemorrhage	Recruiting	2026-09-22

See all 65 active Xiangya Hospital of Central South University trials with filters →

Disease areas by active trials, top 10 of 25

Parkinson's Disease (7) · Lung Cancer (5) · Stroke (5) · Heart Disease (4) · Liver Cancer (3) · Non-Small Cell Lung Cancer (NSCLC) (3) · Prostate Cancer (3) · Anxiety (1) · Asthma (1) · Atopic Dermatitis (1)

Xiangya Hospital of Central South University clinical trial pipeline

What changed in the last 30 days

Etiology Analysis of Chronic Cough After COVID-19 Infection and…Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Development and Validation of a Prognostic Model for Neurocritical…Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring

Organoid-on-chips Technique Based on Biopsy Samples and Its…Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC

ICU · Application of Different Sedation Protocols in ICU · Severe…ICU · Application of Different Sedation Protocols in ICU · Severe Pneumonia

Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics…Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics · Resectable NSCLC

Perioperative Volume Replacement with Volulyte 6% in…Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery

TPExtreme Induced Chemotherapy Followed by Surgery and…TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma

New trial filings, last 30 days

Active trials by phase

Active trials top 25 of 65

Disease areas by active trials, top 10 of 25

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring

Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC

ICU · Application of Different Sedation Protocols in ICU · Severe Pneumonia

Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics · Resectable NSCLC

Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery

TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma